One week on peptides: separating real results from TikTok hype

What did @mondolifts actually say?

In seven days of self-administered peptide injections, @mondolifts reported less chest pain during workouts, faster recovery from soreness, improved skin color, injection-site stinging from GHK-Cu, brief nausea from BPC-157, and increased energy plus libido from MT-2. That last one he attributed to "increased melanin." He is running at least three compounds simultaneously: GHK-Cu (which he calls GHQQ), BPC-157, and MT-2 (Melanotan II). No doses mentioned, no prescribing physician named, no baseline bloodwork referenced. This is a personal anecdote, not a clinical report, and it should be read as exactly that.

Does the science back this up?

Some of it, loosely. BPC-157's injection-site nausea fading after a few days is consistent with anecdotal patterns, though controlled human trials on BPC-157 remain extremely limited. The MT-2 libido claim is real but his explanation for why is wrong. GHK-Cu stinging is a documented nuisance.

BPC-157 (body protection compound 157) has shown regenerative and anti-inflammatory effects in rodent models, including gastric ulcer healing and tendon repair (Sikiric et al., 2018, Current Pharmaceutical Design). Human randomized controlled trials are essentially nonexistent as of 2024. That means every "pro" he lists for BPC-157 is plausible based on animal data but unconfirmed in humans at this point.

GHK-Cu is a naturally occurring copper peptide with real published evidence supporting collagen synthesis and wound repair in cell and animal studies (Pickart et al., 2015, Journal of Aging Science). Injection-site discomfort from copper peptides is reported informally in the peptide-use community but has not been systematically studied.

MT-2 (Melanotan II) does increase libido and energy in clinical studies. A 2000 double-blind trial by Wessells et al. in the International Journal of Impotence Research confirmed erections and libido responses. That part he got right. The mechanism, however, is not melanin.

What did they get wrong (or right)?

The MT-2 mechanism explanation is flat-out incorrect, and it matters. He says "because of the increased melanin, I have just more energy and an increased libido." That is backwards. MT-2 is a synthetic analog of alpha-melanocyte-stimulating hormone (alpha-MSH). It binds melanocortin receptors, particularly MC3R and MC4R in the brain. The libido and energy effects come from central nervous system receptor activation, not from melanin pigment production. Melanin is a downstream cosmetic effect. Conflating the two misleads viewers into thinking a tan causes libido increases.

What he got right: BPC-157 nausea being temporary is consistent with user reports and makes pharmacological sense as the gut adapts. Injection-site stinging with GHK-Cu is a real, commonly reported experience. Crediting these as side effects rather than hiding them is actually responsible content creation. He is also not overclaiming a cure for anything, which keeps him out of the worst category of peptide misinformation.

What should you actually know?

Three things matter here that the video does not address at all.

First, running MT-2 without close monitoring is genuinely risky. MT-2 is not approved by the FDA for any use. It has been associated with nausea, spontaneous erections, darkening of existing moles, and in case reports, activation of dysplastic nevi (Hjuler and Gazerani, 2014, BMJ Case Reports). Dermatologists recommend a full skin check before and during use.

Second, stacking three unregulated peptides simultaneously makes it impossible to attribute any effect, positive or negative, to a single compound. If something goes wrong, you do not know what caused it. If something goes right, you do not know what to credit. This is not a minor methodological quibble; it is the basic logic of knowing what is happening in your own body.

Third, "one week" is not a meaningful timeframe for most peptide mechanisms. BPC-157's proposed tissue-repair effects in animal studies occur over weeks to months. Reporting results at day seven is premature at best, placebo effect at worst.

Should you try what @mondolifts is doing?

That is not a question this fact-check can answer for you, and anyone who says yes without knowing your full medical history is not someone to trust. What the evidence does say: BPC-157 and GHK-Cu have interesting preclinical profiles with very little human trial data to validate them. MT-2 has actual human efficacy data but carries real risks that a seven-day TikTok update will not capture. If you are curious about peptide therapy, the conversation starts with a licensed provider who can review your labs, not a follow button.